Nonsteroidal anti-inflammatory drugs (NSAIDs), which inhibit both the constitutively expressed Cox-1 and inducible Cox-2, show a protective effect in numerous epidemiological studies for the incidence of colorectal cancer (Giovannucci et al, 1995; Smalley et al, 1999). The gene discussed is PTGS2; the disease is colorectal cancer.